Senate’s Medicare drug pricing may ripple into private market
Congress is on the verge of passing historic drug pricing legislation that would allow the government to restrict prices for drugs covered by Medicare, but experts disagree on whether drugmakers will shift those costs to the private market.
Tribune News Service ·